Table 2.
Peptides b | Injected paw width a (mm)
|
||
---|---|---|---|
Before formalin injection | After formalin injectionc | Increase in paw width | |
con-G* | 1.55 ± 0.02 | 2.38 ± 0.03 | 0.83 ± 0.03 |
con-G[S16Y]* | 1.57 ± 0.03 | 2.33 ± 0.05 | 0.76 ± 0.05 |
Ala-con-G | 1.60 ± 0.02 | 2.56 ± 0.05 | 0.97 ± 0.05 |
con-R[1-17] | 1.60 ± 0.04 | 2.60 ± 0.05 | 1.00 ± 0.08 |
ifenprodil | 1.59 ± 0.04 | 2.70 ± 0.04 | 1.10 ± 0.05 |
saline | 1.57 ± 0.03 | 2.53 ± 0.03 | 0.97 ± 0.05 |
Edema was elicited through injection of 20 μl of 5% formalin in saline into the subplantar region of the right hind paw. Data are presented as mean ± S.D. (n = 8).
Peptides (100 pmol) or ifenprodil (25 nmol) were injected intracerebrally (i.c.v.) in a volume of 20 μl.
Measurements were taken 60 min after formalin injection.
Significantly diminished paw swelling compared to the saline control group (p < 0.05, unpaired t test).